DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation, Stripping, Laser, Radiofrequency Ablation), And Segment Forecasts To 2024" report to their offering.
The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to this new report. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.
The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.
The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.
Some key players of the market include
- Medtronic plc
- Angio Dynamics, Inc.
- Biolitec AG
- Syneron Medical Ltd.
- Lumenis Ltd.
- Dornier MedTech GmbH
- Energist Group
- Eufoton S. R.L.
- Vascular Solutions, Inc.
- Quanta Systems S.p.A.
Key Topics Covered:
1. Methodology and Scope
2. Executive Summary
3. Varicose vein treatment Outlook
4. Varicose Vein Type Outlook
5. Varicose vein treatment Regional Outlook
6. Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/ntvf5c/varicose_vein